Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Current Topics in Medicinal Chemistry|June 23, 2007
Melanocortin-4 receptor antagonists as potential therapeutics in the treatment of cachexiaAlan C Foster, Chen Chen
Current Opinion in Pharmacology|December 27, 2005
Glutamate- and GABA-based CNS therapeuticsAlan C Foster, John A Kemp
Pharmacology Research & Perspectives|May 23, 2022
Hearing loss: The final frontier of pharmacologyAlan C Foster, Bonnie E Jacques, Fabrice Piu
Brain Research|March 7, 2002
Ischemic preconditioning reduces infarct volume after subdural hematoma in the ratKenneth B Mackay, Theodore H Stiefel, Alan C Foster
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stressMary Ann Pelleymounter, Margaret Joppa, Nicholas Ling, et al.
Idrugs : the Investigational Drugs Journal|April 1, 2005
MC4 receptor antagonists: a potential treatment for cachexiaAlan C Foster, Chen Chen, Stacy Markison, et al.
Peptides|May 29, 2004
Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin IIIMary Ann Pelleymounter, Margaret Joppa, Nick Ling, et al.
Hearing Research|October 14, 2023
The efficacy of a TrkB monoclonal antibody agonist in preserving the auditory nerve in deafened guinea pigsHenk A Vink, Dyan Ramekers, Alan C Foster, et al.
European Journal of Pharmacology|June 5, 2003
Effects of a selective agonist and antagonist of CRF2 receptors on cardiovascular function in the ratKenneth B Mackay, Theodore H Stiefel, Nick Ling, et al.
Experimental Brain Research|May 3, 2005
Corticotropin-releasing factor: effect on cerebral blood flow in physiologic and ischaemic conditionsManuela De Michele, Omar Touzani, Alan C Foster, et al.
Pageof 7